Arrowhead Pharmaceuticals, Inc.
ARWR
$65.09
$0.010.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 917.47M | 898.17M | 1.10B | 550.84M | 677.46M |
| Total Receivables | 6.82M | 9.70M | 2.37M | 2.50M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.93M | 23.69M | 23.77M | 9.37M | 9.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 15.42M | 15.36M | 13.78M | 7.84M | 8.47M |
| Total Current Assets | 950.64M | 946.92M | 1.14B | 570.54M | 695.47M |
|
|
|||||
| Total Current Assets | 950.64M | 946.92M | 1.14B | 570.54M | 695.47M |
| Net Property, Plant & Equipment | 426.41M | 425.05M | 429.26M | 431.94M | 431.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.86M | 7.29M | 7.71M | 8.14M | 8.56M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.39M | 1.35M | 1.31M | 3.08M | 4.48M |
| Total Assets | 1.39B | 1.38B | 1.57B | 1.01B | 1.14B |
|
|
|||||
| Total Accounts Payable | 17.67M | 33.05M | 9.98M | 14.46M | 11.39M |
| Total Accrued Expenses | 96.24M | 83.77M | 94.71M | 68.10M | 80.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 47.29M | 47.01M | 71.78M | 8.19M | 6.34M |
| Total Finance Division Other Current Liabilities | 34.29M | 30.70M | 44.07M | 3.01M | 4.64M |
| Total Other Current Liabilities | 34.29M | 30.70M | 44.07M | 3.01M | 4.64M |
| Total Current Liabilities | 195.49M | 194.53M | 220.54M | 93.76M | 103.17M |
|
|
|||||
| Total Current Liabilities | 195.49M | 194.53M | 220.54M | 93.76M | 103.17M |
| Long-Term Debt | 582.28M | 560.59M | 561.20M | 754.57M | 734.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 104.11M | 105.69M | 107.53M | 109.30M | 111.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 881.88M | 860.81M | 889.27M | 957.62M | 948.74M |
|
|
|||||
| Common Stock & APIC | 2.14B | 2.12B | 2.11B | 1.85B | 1.81B |
| Retained Earnings | -1.63B | -1.60B | -1.43B | -1.80B | -1.63B |
| Treasury Stock & Other | -46.75M | 5.36M | 4.39M | 4.14M | 4.75M |
| Total Common Equity | 466.05M | 522.31M | 683.32M | 52.59M | 185.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 466.05M | 522.31M | 683.32M | 52.59M | 185.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 37.36M | -2.51M | 904.00K | 3.49M | 5.62M |
| Total Equity | 503.42M | 519.81M | 684.23M | 56.08M | 191.06M |
|
|
|||||